The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma

Ying Li; Feng Zhou; Chao Shen; Yi Su; Yanxia Li; Cuicui Wang; Ruixia Yan; Guiran Yang; Zhenjiang Hou

doi:doi:10.11648/j.ajcem.20210906.15

| Peer-Reviewed

The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma

Ying Li, Feng Zhou, Chao Shen, Yi Su, Yanxia Li, Cuicui Wang, Ruixia Yan, Guiran Yang, Zhenjiang Hou

Published in American Journal of Clinical and Experimental Medicine (Volume 9, Issue 6)

Received: 15 November 2021 Accepted: 6 December 2021 Published: 7 December 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Papillary thyroid carcinoma (PTC) is one of the most common thyroid tumors in clinic. The incidence of papillary thyroid carcinoma is increasing year by year, especially in Cangzhou area, which brings great physical and mental pain to patients. Object: To explore the expression and clinical significance of interleukin-4 (IL-4) and interleukin-13 (IL-13) in the tissues and serum of patients with papillary thyroid carcinoma (PTC). Method: 120 cases of PTC patients were randomly selected as the experimental group, who underwent radical mastectomy at the Thyroid and Breast Surgery Department of Cangzhou Central Hospital from January 2018 to April 2019, and the PTC tissues and their adjacent tissues and serum samples were collected. 120 healthy people were matched 1:1 as the control group in the hospital physical examination center during the same period, according to the gender, age and body mass index of the experimental group, and serum samples were collected. The immunohisto chemical SP method is adopted to test the expression of IL-4 and IL-13 in the tissues, and the ELISA is adopted to test the serum levels of IL-4 and IL-13. Analyze the relationship between IL-4 and IL-13 expression and clinicopathological characteristics in PTC. Result: It was significantly higher with the positive expression rate of IL-4 and IL-13 in PTC tissues than that in adjacent tissues (P<0.05), and it was a significant positive correlation between IL-4 and IL-13 expressed in PTC tissues (r=0.375, P=0.002); It was significantly higher in the serum levels of IL-4 and IL-13 in PTC patients, than that in healthy subjects (P<0.05), and it was a significant positive correlation between IL-4 and IL-13 expressed in the serum of PTC patients (r=0.381, P<0.01); The expression of IL-4 and IL-13 was related to the maximum tumor diameter, TNM stage, degree of differentiation, and lymphatic metastasis in PTC (P<0.05). Conclusion: IL-4 and IL-13 were highly expressed in PTC, and the expression level may become a reference indicator for predicting the occurrence and development of PTC.

Published in	American Journal of Clinical and Experimental Medicine (Volume 9, Issue 6)
DOI	10.11648/j.ajcem.20210906.15
Page(s)	215-222
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Papillary Thyroid Carcinoma, Interleukin-4, Interleukin-13, Clinical Significance

References

[1]	Valvo V, Nucera C. Coding Molecular Determinants of Thyroid Cancer Development and Progression. Endocrinol Metab Clin North Am. 2019 Mar; 48 (1): 37-59.
[2]	Wenlong Zheng, Shuang Zhang, Chengfeng Shen, et al. Analysis of epidemiological characteristics and long-term morbidity and mortality trends of thyroid cancer in Tianjin from 2010 to 2014 [J]. Chinese Cancer, 2018, 27 (9): 670-674.
[3]	Weibin Wang, Xingyun Su, Jiaying Ruan, et al. Clinic pathological and prognostic analysis of 2682 cases of papillary thyroid carcinoma [J]. Chinese Journal of General Surgery, 2018, 33 (5): 393-397.
[4]	Bcb A, Jngda B, Ktcdc C, et al. Polymorphisms at the IL17A and IL17RA genes are associated with prognosis of papillary thyroid carcinoma [J]. Arch Med Res, 2021, 9 (21): 163-166.
[5]	Kumar S, SainiRV, Mahindroo N. Recent advances in cancer immunology and immunology-based anticancer therapies [J]. Biomed Pharmacother, 2017, 96: 1491-1500.
[6]	Han HS, Shin JS, Song YR, et al. Immunostimulatory effects of polysaccharides isolated from young barley leaves (Hordeum vulgare L.) with dual activation of Th1 and Th2 in splenic T cells and cyclophosphamide-induced immunosuppressed mice. Int J BiolMacromol. 2020 Mar 15; 147: 954-964.
[7]	Safar HA, Mustafa AS, Amoudy HA, et al. The effect of adjuvants and delivery systems on Th1, Th2, Th17 and Treg cytokine responses in mice immunized with Mycobacterium tuberculosis-specific proteins. PLoS One. 2020 Feb 6; 15 (2): e0228381.
[8]	Zhao X, Liu J, Ge S, et al. Saikosaponin A Inhibits Breast Cancer by Regulating Th1/Th2 Balance [J]. Frontiers in Pharmacology, 2019, 10: 624.
[9]	Lee H L, Jang J W, Lee S W, et al. Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization [J]. Scientific Reports, 2019, 9 (1): 3260.
[10]	Rui Liu, Qiancheng Luo, Hongling Zhu, et al. Expression of IL-4 and IL-13 in papillary thyroid carcinoma and their relationship with clinic pathological features and prognosis [J]. Journal of Clinical and Pathology, 2018, 38 (03): 490-497.
[11]	Bo Zhang, Jingzhu Xu, Qiong Wu. Interpretation of the 2015 American Thyroid Association "Guidelines for the Diagnosis and Treatment of Adult Thyroid Nodules and Differentiated Thyroid Cancer": Ultrasound Part [J]. Chinese Journal of Cancer, 2016, 26 (1): 19-24.
[12]	Fei Li, Sheyu Li. Global burden of thyroid cancer disease [J]. Chinese General Practice, 2018, 21 (26): 3155-3159.
[13]	Fanping Meng, Po Hao, Hui Fan. Analysis of BRAF-V600E gene expression and T lymphocyte subsets in patients with papillary thyroid carcinoma complicated with Hashimoto’s thyroiditis [J]. Journal of Modern Laboratory Medicine, 2020, 35 (1): 32-34, 48.
[14]	Zaher W, Place S, Gombeir Y. Sudden Development of Subcutaneous Nodules Shortly after Radioiodine Treatment for Thyroid Cancer Caused by Self-Limiting Sarcoidosis. Eur J Case Rep Intern Med. 2020 May 11; 7 (8): 001621.
[15]	Jinnan Wu, Jianrong Chen, Jinliang Chen, et al. Research progress of interleukins in lung cancer tumor microenvironment [J]. Journal of Clinical Pulmonology, 2019, 24 (12): 2280-2283.
[16]	Yang J, Lu Y, Lin Y Y, et al. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma [J]. Cancer Letters, 2016, 383 (1): 18-27.
[17]	Sundary S, Ben W. Hypoxia Pathway Proteins as Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment [J]. Frontiers in Immunology, 2018, 9: 40-47.
[18]	Guo C, Cai J, Xiong L, et al. Effect of IL-4/IL-4R on Biological Behavior of Hepatocellular Carcinoma and Its Underlying Mechanism [J]. Cancer Research on Prevention and Treatment, 2017, 44 (6): 392-397.
[19]	Changkuo Guo, Anwen Liu. Research progress on the relationship between IL-4/IL-4R and tumor [J]. Chemistry of Life, 2017, 37 (03): 413-418.
[20]	Fingleton, Dozier, E. A, et al. IL4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways [J]. Cancer research: The official organ of the American Association for Cancer Research, Inc, 2014, 74 (16): 4329-4340.
[21]	Todaro M, Lombardo Y, Francipane M G, et al. Correction to: Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 [J]. Cell Death and Differentiation, 2019, 26 (12): 1-2.
[22]	Topp M S, Papadimitriou C A, Eitelbach F, et al. Recombinant Human Interleukin 4 Has Antiproliferative Activity on Human Tumor Cell Lines Derived from Epithelial and Nonepithelial Histologies [J]. Cancer Research, 1995, 55 (10): 2173.
[23]	Koller F L, Hwang D G, Dozier E A, et al. Epithelial interleukin-4 receptor expression promotes colon tumor growth [J]. Carcinogenesis, 2010, 31 (6): 1010.
[24]	Conticello C, Pedini F, Zeuner A, et al. IL-4 Protects Tumor Cells from Anti-CD95 and Chemotherapeutic Agents via Up-Regulation of Antiapoptotic Proteins [J]. Journal of Immunology, 2004, 172 (9): 5467-5477.
[25]	Lee S O, Lou W, Hou M, et al. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway [J]. Oncogene, 2003, 22 (39): 6037-6044.
[26]	Kunwar S, Chang S, Westphal M, et al. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol. 2010 Aug; 12 (8): 871-81.
[27]	Ogbuanu IU, Karmaus WJ, Zhang H, et al. Birth order modifies the effect of IL13 gene polymorphisms on serum IgE at age 10 and skin prick test at ages 4, 10 and 18: a prospective birth cohort study. Allergy Asthma Clin Immunol. 2010 Apr 20; 6 (1): 6.
[28]	Li X, Howard TD, Zheng SL, et al. Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol. 2010 Feb; 125 (2): 328-335.
[29]	Seki T, Kumagai T, Kwansa-Bentum B, et al. Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine schistosomiasis japonica. Infect Immun. 2012 Jan; 80 (1): 159-68.
[30]	Hallett MA, Venmar KT, Fingleton B. Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res. 2012 Dec 15; 72 (24): 6338-43.
[31]	Liu H, Antony S, Roy K, et al. Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells. Oncotarget. 2017 Jun 13; 8 (24): 38113-38135.
[32]	Pedroza-Gonzalez A, Xu K, Wu T C, et al. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation [J]. Journal of Experimental Medicine, 2011, 208 (3): 479.
[33]	Cheng, Jianguo. Response to Letter to Editor: Sacroiliac Steroid Injections Do Not Predict Ablation Relief—Not a Surprise [J]. Pain Medicine, 2013, 14 (1): 165-166.
[34]	Wenlin Li, Hong Wu, Chuang Meng, et al. The effect of IL-13 on the expression of Bcl-2 and TIGAR in breast cancer cells co-cultured with fibroblasts [J]. Journal of Immunology, 2016, 32 (02): 93-97.
[35]	Ozlu E, Karadag A S, Toprak A E, et al. Evaluation of Cardiovascular Risk Factors, Haematological and Biochemical Parameters, and Serum Endocan Levels in Patients with Lichen Planus [J]. Dermatology, 2016, 232: 438-443.
[36]	Xiujuan Li, Huanfang Fan, Jiaojiao Yan, et al. Changes in Th1/Th2 cytokine levels and their correlation analysis in patients with gastric cancer [J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2021, 30 (09): 991-995.
[37]	Jingbin Zhang, Da Li, Yutong Cao, et al. The clinical significance of evaluation of peripheral blood immune function in patients with Hashimoto's thyroiditis during perimenopause [J]. China Maternal and Child Health Care, 2021, 36 (06): 1402-1404.
[38]	Qing Wei, YaboGao, Jiacheng Xiao, et al. The expression and correlation of IL-13 and CXCR4 in papillary thyroid carcinoma [J]. Chinese Journal of Endocrine Surgery, 2010, 4 (2): 73-75.

Cite This Article

Plain Text BibTeX RIS

APA Style

Ying Li, Feng Zhou, Chao Shen, Yi Su, Yanxia Li, et al. (2021). The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma. American Journal of Clinical and Experimental Medicine, 9(6), 215-222. https://doi.org/10.11648/j.ajcem.20210906.15

Copy | Download

ACS Style

Ying Li; Feng Zhou; Chao Shen; Yi Su; Yanxia Li, et al. The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma. Am. J. Clin. Exp. Med. 2021, 9(6), 215-222. doi: 10.11648/j.ajcem.20210906.15

Copy | Download

AMA Style

Ying Li, Feng Zhou, Chao Shen, Yi Su, Yanxia Li, et al. The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma. Am J Clin Exp Med. 2021;9(6):215-222. doi: 10.11648/j.ajcem.20210906.15

Copy | Download

@article{10.11648/j.ajcem.20210906.15,
  author = {Ying Li and Feng Zhou and Chao Shen and Yi Su and Yanxia Li and Cuicui Wang and Ruixia Yan and Guiran Yang and Zhenjiang Hou},
  title = {The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma},
  journal = {American Journal of Clinical and Experimental Medicine},
  volume = {9},
  number = {6},
  pages = {215-222},
  doi = {10.11648/j.ajcem.20210906.15},
  url = {https://doi.org/10.11648/j.ajcem.20210906.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajcem.20210906.15},
  abstract = {Papillary thyroid carcinoma (PTC) is one of the most common thyroid tumors in clinic. The incidence of papillary thyroid carcinoma is increasing year by year, especially in Cangzhou area, which brings great physical and mental pain to patients. Object: To explore the expression and clinical significance of interleukin-4 (IL-4) and interleukin-13 (IL-13) in the tissues and serum of patients with papillary thyroid carcinoma (PTC). Method: 120 cases of PTC patients were randomly selected as the experimental group, who underwent radical mastectomy at the Thyroid and Breast Surgery Department of Cangzhou Central Hospital from January 2018 to April 2019, and the PTC tissues and their adjacent tissues and serum samples were collected. 120 healthy people were matched 1:1 as the control group in the hospital physical examination center during the same period, according to the gender, age and body mass index of the experimental group, and serum samples were collected. The immunohisto chemical SP method is adopted to test the expression of IL-4 and IL-13 in the tissues, and the ELISA is adopted to test the serum levels of IL-4 and IL-13. Analyze the relationship between IL-4 and IL-13 expression and clinicopathological characteristics in PTC. Result: It was significantly higher with the positive expression rate of IL-4 and IL-13 in PTC tissues than that in adjacent tissues (PConclusion: IL-4 and IL-13 were highly expressed in PTC, and the expression level may become a reference indicator for predicting the occurrence and development of PTC.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma
AU  - Ying Li
AU  - Feng Zhou
AU  - Chao Shen
AU  - Yi Su
AU  - Yanxia Li
AU  - Cuicui Wang
AU  - Ruixia Yan
AU  - Guiran Yang
AU  - Zhenjiang Hou
Y1  - 2021/12/07
PY  - 2021
N1  - https://doi.org/10.11648/j.ajcem.20210906.15
DO  - 10.11648/j.ajcem.20210906.15
T2  - American Journal of Clinical and Experimental Medicine
JF  - American Journal of Clinical and Experimental Medicine
JO  - American Journal of Clinical and Experimental Medicine
SP  - 215
EP  - 222
PB  - Science Publishing Group
SN  - 2330-8133
UR  - https://doi.org/10.11648/j.ajcem.20210906.15
AB  - Papillary thyroid carcinoma (PTC) is one of the most common thyroid tumors in clinic. The incidence of papillary thyroid carcinoma is increasing year by year, especially in Cangzhou area, which brings great physical and mental pain to patients. Object: To explore the expression and clinical significance of interleukin-4 (IL-4) and interleukin-13 (IL-13) in the tissues and serum of patients with papillary thyroid carcinoma (PTC). Method: 120 cases of PTC patients were randomly selected as the experimental group, who underwent radical mastectomy at the Thyroid and Breast Surgery Department of Cangzhou Central Hospital from January 2018 to April 2019, and the PTC tissues and their adjacent tissues and serum samples were collected. 120 healthy people were matched 1:1 as the control group in the hospital physical examination center during the same period, according to the gender, age and body mass index of the experimental group, and serum samples were collected. The immunohisto chemical SP method is adopted to test the expression of IL-4 and IL-13 in the tissues, and the ELISA is adopted to test the serum levels of IL-4 and IL-13. Analyze the relationship between IL-4 and IL-13 expression and clinicopathological characteristics in PTC. Result: It was significantly higher with the positive expression rate of IL-4 and IL-13 in PTC tissues than that in adjacent tissues (PConclusion: IL-4 and IL-13 were highly expressed in PTC, and the expression level may become a reference indicator for predicting the occurrence and development of PTC.
VL  - 9
IS  - 6
ER  -

Copy | Download

Author Information

Ying Li

Department of Medical Technology, Cangzhou Medical College, Cangzhou, China
Feng Zhou

Department of Medical Technology, Cangzhou Medical College, Cangzhou, China
Chao Shen

Department of Medical Technology, Cangzhou Medical College, Cangzhou, China
Yi Su

Thyroid and Breast Surgical Department, People's Hospital of Nanpi County, Cangzhou, China
Yanxia Li

Department of Rheumatology and Immunology, Cangzhou Central Hospital, Cangzhou, China
Cuicui Wang

Department of Medical Technology, Cangzhou Medical College, Cangzhou, China
Ruixia Yan

Department of Medical Technology, Cangzhou Medical College, Cangzhou, China
Guiran Yang

Department of Medical Technology, Cangzhou Medical College, Cangzhou, China
Zhenjiang Hou

Institute of Thyroid Diseases Affiliated to Cangzhou Medical College, Cangzhou Thyroid Disease Engineering Technology Research Center, Cangzhou, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Ying Li, Feng Zhou, Chao Shen, Yi Su, Yanxia Li, et al. (2021). The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma. American Journal of Clinical and Experimental Medicine, 9(6), 215-222. https://doi.org/10.11648/j.ajcem.20210906.15

Copy | Download

ACS Style

Ying Li; Feng Zhou; Chao Shen; Yi Su; Yanxia Li, et al. The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma. Am. J. Clin. Exp. Med. 2021, 9(6), 215-222. doi: 10.11648/j.ajcem.20210906.15

Copy | Download

AMA Style

Ying Li, Feng Zhou, Chao Shen, Yi Su, Yanxia Li, et al. The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma. Am J Clin Exp Med. 2021;9(6):215-222. doi: 10.11648/j.ajcem.20210906.15

Copy | Download

@article{10.11648/j.ajcem.20210906.15,
  author = {Ying Li and Feng Zhou and Chao Shen and Yi Su and Yanxia Li and Cuicui Wang and Ruixia Yan and Guiran Yang and Zhenjiang Hou},
  title = {The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma},
  journal = {American Journal of Clinical and Experimental Medicine},
  volume = {9},
  number = {6},
  pages = {215-222},
  doi = {10.11648/j.ajcem.20210906.15},
  url = {https://doi.org/10.11648/j.ajcem.20210906.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajcem.20210906.15},
  abstract = {Papillary thyroid carcinoma (PTC) is one of the most common thyroid tumors in clinic. The incidence of papillary thyroid carcinoma is increasing year by year, especially in Cangzhou area, which brings great physical and mental pain to patients. Object: To explore the expression and clinical significance of interleukin-4 (IL-4) and interleukin-13 (IL-13) in the tissues and serum of patients with papillary thyroid carcinoma (PTC). Method: 120 cases of PTC patients were randomly selected as the experimental group, who underwent radical mastectomy at the Thyroid and Breast Surgery Department of Cangzhou Central Hospital from January 2018 to April 2019, and the PTC tissues and their adjacent tissues and serum samples were collected. 120 healthy people were matched 1:1 as the control group in the hospital physical examination center during the same period, according to the gender, age and body mass index of the experimental group, and serum samples were collected. The immunohisto chemical SP method is adopted to test the expression of IL-4 and IL-13 in the tissues, and the ELISA is adopted to test the serum levels of IL-4 and IL-13. Analyze the relationship between IL-4 and IL-13 expression and clinicopathological characteristics in PTC. Result: It was significantly higher with the positive expression rate of IL-4 and IL-13 in PTC tissues than that in adjacent tissues (PConclusion: IL-4 and IL-13 were highly expressed in PTC, and the expression level may become a reference indicator for predicting the occurrence and development of PTC.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - The Expression and Clinical Significance of IL-4 and IL-13 in Papillary Thyroid Carcinoma
AU  - Ying Li
AU  - Feng Zhou
AU  - Chao Shen
AU  - Yi Su
AU  - Yanxia Li
AU  - Cuicui Wang
AU  - Ruixia Yan
AU  - Guiran Yang
AU  - Zhenjiang Hou
Y1  - 2021/12/07
PY  - 2021
N1  - https://doi.org/10.11648/j.ajcem.20210906.15
DO  - 10.11648/j.ajcem.20210906.15
T2  - American Journal of Clinical and Experimental Medicine
JF  - American Journal of Clinical and Experimental Medicine
JO  - American Journal of Clinical and Experimental Medicine
SP  - 215
EP  - 222
PB  - Science Publishing Group
SN  - 2330-8133
UR  - https://doi.org/10.11648/j.ajcem.20210906.15
AB  - Papillary thyroid carcinoma (PTC) is one of the most common thyroid tumors in clinic. The incidence of papillary thyroid carcinoma is increasing year by year, especially in Cangzhou area, which brings great physical and mental pain to patients. Object: To explore the expression and clinical significance of interleukin-4 (IL-4) and interleukin-13 (IL-13) in the tissues and serum of patients with papillary thyroid carcinoma (PTC). Method: 120 cases of PTC patients were randomly selected as the experimental group, who underwent radical mastectomy at the Thyroid and Breast Surgery Department of Cangzhou Central Hospital from January 2018 to April 2019, and the PTC tissues and their adjacent tissues and serum samples were collected. 120 healthy people were matched 1:1 as the control group in the hospital physical examination center during the same period, according to the gender, age and body mass index of the experimental group, and serum samples were collected. The immunohisto chemical SP method is adopted to test the expression of IL-4 and IL-13 in the tissues, and the ELISA is adopted to test the serum levels of IL-4 and IL-13. Analyze the relationship between IL-4 and IL-13 expression and clinicopathological characteristics in PTC. Result: It was significantly higher with the positive expression rate of IL-4 and IL-13 in PTC tissues than that in adjacent tissues (PConclusion: IL-4 and IL-13 were highly expressed in PTC, and the expression level may become a reference indicator for predicting the occurrence and development of PTC.
VL  - 9
IS  - 6
ER  -

Copy | Download